These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 34742747)

  • 21. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
    Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
    J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ionizable Lipid Nanoparticles for
    Swingle KL; Safford HC; Geisler HC; Hamilton AG; Thatte AS; Billingsley MM; Joseph RA; Mrksich K; Padilla MS; Ghalsasi AA; Alameh MG; Weissman D; Mitchell MJ
    J Am Chem Soc; 2023 Mar; 145(8):4691-4706. PubMed ID: 36789893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach.
    Young RE; Nelson KM; Hofbauer SI; Vijayakumar T; Alameh MG; Weissman D; Papachristou C; Gleghorn JP; Riley RS
    Bioact Mater; 2024 Apr; 34():125-137. PubMed ID: 38223537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies.
    Nabar N; Dacoba TG; Covarrubias G; Romero-Cruz D; Hammond PT
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307809121. PubMed ID: 38437543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
    Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
    Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic Lipid Pairs Enhance Liver-to-Lung Tropism of Lipid Nanoparticles for In Vivo mRNA Delivery.
    Zeng G; He Z; Yang H; Gao Z; Ge X; Liu L; Liu Z; Chen Y
    ACS Appl Mater Interfaces; 2024 May; 16(20):25698-25709. PubMed ID: 38717294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery.
    Wang X; Liu S; Sun Y; Yu X; Lee SM; Cheng Q; Wei T; Gong J; Robinson J; Zhang D; Lian X; Basak P; Siegwart DJ
    Nat Protoc; 2023 Jan; 18(1):265-291. PubMed ID: 36316378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
    Francia V; Schiffelers RM; Cullis PR; Witzigmann D
    Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient delivery of VEGFA mRNA for promoting wound healing via ionizable lipid nanoparticles.
    Dong S; Wang J; Guo Z; Zhang Y; Zha W; Wang Y; Liu C; Xing H; Li X
    Bioorg Med Chem; 2023 Jan; 78():117135. PubMed ID: 36577327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood-Brain Barrier Transfection and Crossing.
    Han EL; Padilla MS; Palanki R; Kim D; Mrksich K; Li JJ; Tang S; Yoon IC; Mitchell MJ
    Nano Lett; 2024 Feb; 24(5):1477-1486. PubMed ID: 38259198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
    Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
    SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Combinatorial Library of Lipid Nanoparticles for Cell Type-Specific mRNA Delivery.
    Naidu GS; Yong SB; Ramishetti S; Rampado R; Sharma P; Ezra A; Goldsmith M; Hazan-Halevy I; Chatterjee S; Aitha A; Peer D
    Adv Sci (Weinh); 2023 Jul; 10(19):e2301929. PubMed ID: 37092557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A magnetic separation method for isolating and characterizing the biomolecular corona of lipid nanoparticles.
    Francia V; Zhang Y; Cheng MHY; Schiffelers RM; Witzigmann D; Cullis PR
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307803120. PubMed ID: 38437542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment.
    Xue L; Gong N; Shepherd SJ; Xiong X; Liao X; Han X; Zhao G; Song C; Huang X; Zhang H; Padilla MS; Qin J; Shi Y; Alameh MG; Pochan DJ; Wang K; Long F; Weissman D; Mitchell MJ
    J Am Chem Soc; 2022 Jun; 144(22):9926-9937. PubMed ID: 35616998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Ionizable Lipid Nanoparticles for SARS-CoV-2 Omicron mRNA Delivery.
    Long J; Yu C; Zhang H; Cao Y; Sang Y; Lu H; Zhang Z; Wang X; Wang H; Song G; Yang J; Wang S
    Adv Healthc Mater; 2023 May; 12(13):e2202590. PubMed ID: 36716702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid nanoparticle structure and delivery route during pregnancy dictate mRNA potency, immunogenicity, and maternal and fetal outcomes.
    Chaudhary N; Newby AN; Arral ML; Yerneni SS; LoPresti ST; Doerfler R; Petersen DMS; Montoya C; Kim JS; Fox B; Coon T; Malaney A; Sadovsky Y; Whitehead KA
    Proc Natl Acad Sci U S A; 2024 Mar; 121(11):e2307810121. PubMed ID: 38437545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells.
    Billingsley MM; Hamilton AG; Mai D; Patel SK; Swingle KL; Sheppard NC; June CH; Mitchell MJ
    Nano Lett; 2022 Jan; 22(1):533-542. PubMed ID: 34669421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.